[go: up one dir, main page]

MX2009008548A - Formulaciones de olopatadina para administracion nasal topica. - Google Patents

Formulaciones de olopatadina para administracion nasal topica.

Info

Publication number
MX2009008548A
MX2009008548A MX2009008548A MX2009008548A MX2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A
Authority
MX
Mexico
Prior art keywords
nasal administration
olopatadine
topical nasal
olopatadine formulations
formulations
Prior art date
Application number
MX2009008548A
Other languages
English (en)
Inventor
Onkar N Singh
G Michael Wall
Rajni Jani
Masood A Chowhan
Wesley Wehsin Han
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MX2009008548A publication Critical patent/MX2009008548A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen formulaciones tópicas de olopatadina para el tratamiento de trastornos alérgicos o inflamatorios de la nariz; las formulaciones acuosas contienen aproximadamente 0.6% (p/v) de olopatadina.
MX2009008548A 2007-02-07 2007-02-07 Formulaciones de olopatadina para administracion nasal topica. MX2009008548A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/003285 WO2008097220A1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration

Publications (1)

Publication Number Publication Date
MX2009008548A true MX2009008548A (es) 2009-08-18

Family

ID=38542957

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008548A MX2009008548A (es) 2007-02-07 2007-02-07 Formulaciones de olopatadina para administracion nasal topica.

Country Status (15)

Country Link
EP (2) EP2977042B1 (es)
JP (1) JP5149308B2 (es)
KR (1) KR20100014858A (es)
CN (1) CN101621989A (es)
AU (1) AU2007346121B2 (es)
BR (1) BRPI0721255B8 (es)
CA (1) CA2677631C (es)
DK (1) DK2114367T3 (es)
ES (2) ES2557939T3 (es)
HU (1) HUE026162T2 (es)
MX (1) MX2009008548A (es)
PL (1) PL2114367T3 (es)
PT (1) PT2114367E (es)
SI (1) SI2114367T1 (es)
WO (1) WO2008097220A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
SI2453872T1 (sl) * 2009-07-17 2013-10-30 Alcon Research, Ltd. Režim za olopatadinsko pršilo za nos
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
CN103830219A (zh) * 2012-11-20 2014-06-04 深圳大佛药业有限公司 一种稳定的奥洛他定组合物
US20230018472A1 (en) * 2019-12-06 2023-01-19 Toko Yakuhin Kogyo Co., Ltd. Rhinenchysis composition containing olopatadine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
CA2504200A1 (en) * 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
AU2005309951B2 (en) 2004-11-24 2011-07-07 Alcon, Inc. Method of delivering nasal spray

Also Published As

Publication number Publication date
AU2007346121A1 (en) 2008-08-14
CA2677631A1 (en) 2008-08-14
EP2977042B1 (en) 2020-01-01
JP5149308B2 (ja) 2013-02-20
EP2977042A1 (en) 2016-01-27
CN101621989A (zh) 2010-01-06
BRPI0721255B1 (pt) 2019-08-27
BRPI0721255B8 (pt) 2021-05-25
ES2781090T3 (es) 2020-08-28
KR20100014858A (ko) 2010-02-11
DK2114367T3 (en) 2015-12-07
EP2114367A1 (en) 2009-11-11
ES2557939T3 (es) 2016-01-29
SI2114367T1 (sl) 2016-01-29
PT2114367E (pt) 2016-02-01
AU2007346121B2 (en) 2012-08-23
CA2677631C (en) 2014-05-13
HUE026162T2 (en) 2016-05-30
HK1217090A1 (en) 2016-12-23
JP2010518075A (ja) 2010-05-27
WO2008097220A1 (en) 2008-08-14
PL2114367T3 (pl) 2016-03-31
EP2114367B1 (en) 2015-11-04
BRPI0721255A2 (pt) 2013-01-01

Similar Documents

Publication Publication Date Title
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
MX2010004026A (es) Piperidino-dihidrotienopirimidinas sustituidas.
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
MX2010001242A (es) Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos.
EA019970B8 (ru) Производные имидазолидиндиона
WO2009003199A8 (en) Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EP3632444A3 (en) Topical lfa-1 antagonists for use in localized treatment of immune related disorders
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
MX337594B (es) Formulaciones de quinonas para tratamiento de padecimientos oftalmicos.
MX363435B (es) Formulaciones topicas que tienen biodisponibilidad aumentada.
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
MX2007006558A (es) Formulaciones topicas de nepafenac.
MX2010003346A (es) Piperazino-dihidrotienopirimidinas sustituidas en heterociclo.
UA99524C2 (ru) Триазолопроизводные, полезные для лечения болезней
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
WO2008002621A3 (en) Benzyl-substituted quinolone m1 receptor positive allosteric modulators
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2008012400A (es) Azolopirimidinas como inhibidores de actividad de cannabinoide 1.
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
NO20084328L (no) Nye forbindelser
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
MX2010002736A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
WO2008012338A3 (en) Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration